{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:39:39Z","timestamp":1783633179048,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ecl.2015.02.008","type":"journal-article","created":{"date-parts":[[2015,3,21]],"date-time":"2015-03-21T19:28:26Z","timestamp":1426966106000},"page":"435-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Surgical Management of Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Gustavo G.","family":"Fernandez Ranvier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William B.","family":"Inabnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ecl.2015.02.008_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.ecl.2015.02.008_bib2","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib3","first-page":"348","article-title":"Adrenocortical carcinoma","volume":"37","author":"Brennan","year":"1987","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.ecl.2015.02.008_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00268-001-0030-7","article-title":"Adrenal cortical carcinoma","volume":"25","author":"Dackiw","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib5","series-title":"Endocrine tumors: American Cancer Society, atlas of clinical oncology","first-page":"123","article-title":"Adrenocortical carcinoma","author":"Fehaily","year":"2003"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib6","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2015.02.008_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9343(66)90219-1","article-title":"Adrenal cortical carcinoma. Clinical features of 138 patients","volume":"41","author":"Hutter","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib8","first-page":"5","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y","article-title":"Risk factors for adrenal cancer: an exploratory study","volume":"65","author":"Hsing","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1464-410X.1998.00726.x","article-title":"Diagnosis and treatment of adrenal tumours: a review of 35 years' experience","volume":"82","author":"Xiao","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib12","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib13","first-page":"76","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6\u20137","key":"10.1016\/j.ecl.2015.02.008_bib14","first-page":"385","article-title":"Malignant adrenocortical tumor as a part of Wermer's syndrome. Apropos of a case","volume":"126","author":"Houdelette","year":"1989","journal-title":"J\u00a0Chir (Paris)"},{"issue":"2","key":"10.1016\/j.ecl.2015.02.008_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2015.02.008_bib16","first-page":"2027","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib17","first-page":"1116","article-title":"Comparative genomic hybridization analysis of adrenocortical tumors of childhood","volume":"84","author":"Figueiredo","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2015.02.008_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2004-0942","article-title":"Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors","volume":"90","author":"Figueiredo","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001622-200401000-00004","article-title":"Adrenocortical cancer: recent clinical and molecular advances","volume":"16","author":"Sidhu","year":"2004","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"10.1016\/j.ecl.2015.02.008_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib21","first-page":"963","article-title":"An eleven-year experience with adrenocortical carcinoma","volume":"112","author":"Pommier","year":"1992","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ecl.2015.02.008_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archsurg.136.5.543","article-title":"Adrenocortical carcinoma: surgical progress or status quo?","volume":"136","author":"Kendrick","year":"2001","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib23","first-page":"1120","article-title":"Early experience with laparoscopic approach for adrenalectomy","volume":"114","author":"Gagner","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.008_bib24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jcem.87.7.8697","article-title":"Comparative genomic hybridization analysis of adrenocortical tumors","volume":"87","author":"Sidhu","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/erc.1.01130","article-title":"Adrenocortical cancer: pathophysiology and clinical management","volume":"14","author":"Lib\u00e8","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib26","first-page":"6762","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ecl.2015.02.008_bib27","first-page":"322","article-title":"High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors","volume":"85","author":"Bourcigaux","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib28","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2015.02.008_bib29","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.10.019","article-title":"Molecular epidemiology of adrenocortical tumors in southern Brazil","volume":"351","author":"Cust\u00f3dio","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.008_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.2910540310","article-title":"p53 mutations in sporadic adrenocortical tumors","volume":"54","author":"Ohgaki","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.0.1450207","article-title":"Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors","volume":"145","author":"Barzon","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.008_bib34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-06-2085","article-title":"Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity","volume":"13","author":"Lib\u00e8","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2015.02.008_bib35","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/86.22.1707","article-title":"High frequency of germline p53 mutations in childhood adrenocortical cancer","volume":"86","author":"Wagner","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ecl.2015.02.008_bib36","first-page":"790","article-title":"p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies","volume":"78","author":"Reincke","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib37","first-page":"660","article-title":"Adrenal cortical carcinoma","volume":"120","author":"Sullivan","year":"1978","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib38","first-page":"1444","article-title":"Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors","volume":"78","author":"Gicquel","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib39","first-page":"2559","article-title":"Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors","volume":"82","author":"Gicquel","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib40","first-page":"5358","article-title":"A\u00a0cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ecl.2015.02.008_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jmg.2008.057570","article-title":"Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families","volume":"45","author":"Bougeard","year":"2008","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2015.02.008_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2015.02.008_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1043-2760(00)00372-6","article-title":"Multiple endocrine neoplasia type 1: new clinical and basic findings","volume":"12","author":"Schussheim","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0039-6060(96)80164-4","article-title":"The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group","volume":"119","author":"Crucitti","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.008_bib45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I","article-title":"Adrenocortical carcinoma. Clinical outcome at the end of the 20th century","volume":"92","author":"Vassilopoulou-Sellin","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.008_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12022-014-9307-x","article-title":"Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature","volume":"25","author":"Griffin","year":"2014","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2015.02.008_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpedsurg.2004.01.029","article-title":"A\u00a0surgical approach to adrenocortical tumors in children: the mainstay of treatment","volume":"39","author":"Stewart","year":"2004","journal-title":"J\u00a0Pediatr Surg"},{"issue":"5","key":"10.1016\/j.ecl.2015.02.008_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4158\/EP.15.5.450","article-title":"American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ecl.2015.02.008_bib52","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2015.02.008_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03351068","article-title":"Adrenal tumors: how to establish malignancy?","volume":"27","author":"Fassnacht","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.008_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","article-title":"The optimal imaging of adrenal tumours: a comparison of different methods","volume":"14","author":"Ilias","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MOU.0b013e328011ea00","article-title":"Imaging of adrenal masses","volume":"17","author":"Heinz-Peer","year":"2007","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib56","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib57","first-page":"884","article-title":"The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses","volume":"42","author":"Maurea","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib58","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","article-title":"Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma","volume":"91","author":"Mackie","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib59","first-page":"289","article-title":"FDG-PET in adrenocortical carcinoma","volume":"16","author":"Becherer","year":"2001","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ecl.2015.02.008_bib60","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","article-title":"Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography","volume":"91","author":"Leboulleux","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib61","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1500789","article-title":"18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients","volume":"150","author":"Tenenbaum","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib62","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12672-011-0093-3","article-title":"Metomidate-based imaging of adrenal masses","volume":"2","author":"Hahner","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib63","first-page":"32","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses","volume":"47","author":"Metser","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acra.2007.01.009","article-title":"Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET\/CT: quantitative and qualitative evaluation","volume":"14","author":"Caoili","year":"2007","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ecl.2015.02.008_bib65","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1148\/radiol.2383042164","article-title":"Adrenal lesions: characterization with fused PET\/CT image in patients with proved or suspected malignancy\u2013initial experience","volume":"238","author":"Blake","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ecl.2015.02.008_bib66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/cncr.20498","article-title":"Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients","volume":"102","author":"Jhala","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcu.10220","article-title":"Role of sonographically guided fine-needle aspiration biopsy of adrenal masses in patients with lung cancer","volume":"32","author":"Kocijancic","year":"2004","journal-title":"J\u00a0Clin Ultrasound"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.008_bib69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00004728-199505000-00017","article-title":"Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications","volume":"19","author":"Mody","year":"1995","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"8","key":"10.1016\/j.ecl.2015.02.008_bib70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archsurg.141.8.771","article-title":"Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases","volume":"141","author":"Shen","year":"2006","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib71","first-page":"1085","article-title":"Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome","volume":"108","author":"Doherty","year":"1990","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.008_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.surg.2011.09.030","article-title":"Recommendation for standardized surgical management of primary adrenocortical carcinoma","volume":"152","author":"Gaujoux","year":"2012","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ecl.2015.02.008_bib73","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.134.2.181","article-title":"Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection","volume":"134","author":"Harrison","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3182367ac3","article-title":"Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma","volume":"255","author":"Reibetanz","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajcp\/72.3.390","article-title":"Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data","volume":"72","author":"Hough","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ecl.2015.02.008_bib76","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/archsurg.137.8.948","article-title":"Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms","volume":"137","author":"Kebebew","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib77","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.surg.2005.09.012","article-title":"Laparoscopic resection of adrenal cortical carcinoma: a cautionary note","volume":"138","author":"Gonzalez","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.008_bib78","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00268-010-0532-2","article-title":"Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma","volume":"34","author":"Miller","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archsurg.139.1.46","article-title":"Applicability of laparoscopic adrenalectomy in a prospective study in 150 consecutive patients","volume":"139","author":"Prager","year":"2004","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.008_bib80","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.surg.2012.08.014","article-title":"Open versus endoscopic adrenalectomy in the treatment of localized (stage I\/II) adrenocortical carcinoma: results of a multiinstitutional Italian survey","volume":"152","author":"Lombardi","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.008_bib81","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.eururo.2011.07.062","article-title":"Contemporary management of adrenocortical carcinoma","volume":"60","author":"Zini","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib82","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MOU.0b013e3282f3e6d2","article-title":"Laparoscopic radical adrenalectomy for cancer: long-term outcomes","volume":"18","author":"McCauley","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib83","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.eururo.2010.01.036","article-title":"Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer","volume":"57","author":"Porpiglia","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib84","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.eururo.2010.06.024","article-title":"Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients","volume":"58","author":"Brix","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ecl.2015.02.008_bib85","unstructured":"Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00777244?term=adrenocortical+carcinoma&rank=20. Accessed October 2, 2014."},{"key":"10.1016\/j.ecl.2015.02.008_bib86","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ecl.2015.02.008_bib87","first-page":"155","article-title":"Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases","volume":"23","author":"Macfarlane","year":"1958","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ecl.2015.02.008_bib88","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.008_bib89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9343(81)90384-3","article-title":"Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978)","volume":"71","author":"Bertagna","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib90","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2010-0803","article-title":"Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers","volume":"95","author":"Fassnacht","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib91","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s002689900442","article-title":"Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up","volume":"22","author":"Khorram-Manesh","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2015.02.008_bib92","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib93","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/1097-0142(19950515)75:10<2587::AID-CNCR2820751028>3.0.CO;2-5","article-title":"Adrenocortical carcinoma. A clinical study and treatment results of 52 patients","volume":"75","author":"Kasperlik-Za\u0142uska","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib94","first-page":"3100","article-title":"Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?","volume":"83","author":"Dickstein","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib95","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1590\/S0100-879X2000001000008","article-title":"Clinical results of the use of mitotane for adrenocortical carcinoma","volume":"33","author":"Kasperlik-Zaluska","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ecl.2015.02.008_bib96","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1056\/NEJMe078087","article-title":"Adjuvant mitotane therapy of adrenal cancer - use and controversy","volume":"356","author":"Schteingart","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib97","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/1097-0142(19930515)71:10<3119::AID-CNCR2820711037>3.0.CO;2-8","article-title":"Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer","volume":"71","author":"Vassilopoulou-Sellin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib98","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.1994.183","article-title":"Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients","volume":"69","author":"Haak","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib99","first-page":"1488","article-title":"Comment\u2013Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?","volume":"84","author":"Barzon","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.008_bib100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: a 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2015.02.008_bib101","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2009.27.5958","article-title":"Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel","volume":"28","author":"Berruti","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: a clinician's update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.008_bib103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib104","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.02.008_bib105","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/cncr.10487","article-title":"A\u00a0phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist","volume":"94","author":"Abraham","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib106","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.1998.530","article-title":"Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma","volume":"78","author":"Bonacci","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib107","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/ERC-09-0281","article-title":"Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-\/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study","volume":"17","author":"Sperone","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib108","first-page":"513","article-title":"Cisplatin for adrenal cortical carcinoma","volume":"67","author":"Chun","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ecl.2015.02.008_bib109","first-page":"909","article-title":"Cytotoxic chemotherapy in adrenal cortical carcinoma","volume":"64","author":"Haq","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ecl.2015.02.008_bib110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1159::AID-CNCR28>3.0.CO;2-R","article-title":"Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study","volume":"88","author":"Williamson","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/MO:21:2:167","article-title":"Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer","volume":"21","author":"Khan","year":"2004","journal-title":"Med Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib112","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/cncr.24331","article-title":"Radiotherapy in adrenocortical carcinoma","volume":"115","author":"Polat","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2015.02.008_bib113","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","article-title":"Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma","volume":"91","author":"Fassnacht","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2012-2367","article-title":"A\u00a0retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma","volume":"98","author":"Habra","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.008_bib115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2010.04.030","article-title":"Adjuvant and definitive radiotherapy for adrenocortical carcinoma","volume":"80","author":"Sabolch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ecl.2015.02.008_bib116","first-page":"500","article-title":"Adrenocortical carcinoma. A retrospective study of a rare tumor with a poor prognosis","volume":"16","author":"Gr\u00f6ndal","year":"1990","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib117","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0039-6109(16)44193-9","article-title":"Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas","volume":"67","author":"Thompson","year":"1987","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ecl.2015.02.008_bib118","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1245\/s10434-012-2358-7","article-title":"Resection of adrenocortical carcinoma liver metastasis: is it justified?","volume":"19","author":"Gaujoux","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib119","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","article-title":"Operative management for recurrent and metastatic adrenocortical carcinoma","volume":"105","author":"Datrice","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ecl.2015.02.008_bib121","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0039-6060(97)90229-4","article-title":"Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma","volume":"122","author":"Bellantone","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.008_bib122","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.2003.01881.x","article-title":"Management of adrenocortical carcinoma","volume":"60","author":"Allolio","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2015.02.008_bib123","first-page":"526","article-title":"Mitotane increases the blood levels of hormone-binding proteins","volume":"124","author":"van Seters","year":"1991","journal-title":"Acta Endocrinol (Copenh)"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:41:21Z","timestamp":1760175681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852915000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0889852915000092"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2015.02.008","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Management of Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2015.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}